A case of mannitol hypersensitivity

Journal of Pediatric Hematology/Oncology

Volumn 35, Issue 7, 2013, Pages

  Lightner, Donita D ^a   Braganca, Kevin De ^a   Gilheeney, Stephen W ^a   Khakoo, Yasmin ^a,b   Kramer, Kim ^a   Balas, Morad ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

anaphylaxis; cisplatin; mannitol; medical oncology; support care

Indexed keywords

ATROPINE; CISPLATIN; DIPHENHYDRAMINE; GLYCOPYRRONIUM BROMIDE; HYDROCORTISONE; HYDROXYZINE; MANNITOL; MORPHINE; RANITIDINE; SUXAMETHONIUM; VANCOMYCIN;

ADULT; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CANCER STAGING; CASE REPORT; CONSCIOUSNESS DISORDER; CONTINUOUS INFUSION; COUGHING; DEATH; DIURESIS; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPNEA; FEVER; FLUSHING; HOSPITAL ADMISSION; HUMAN; HYDRATION; HYPERSENSITIVITY; MACULOPAPULAR RASH; MALE; MEDICAL HISTORY; NEPHROTOXICITY; NEUTROPENIA; PRIORITY JOURNAL; RHABDOID TUMOR; SIDE EFFECT; TACHYCARDIA; TECTAL ATYPICAL TERATOID RHABDOID TUMOR;

ANAPHYLAXIS; DIPHENHYDRAMINE; DRUG HYPERSENSITIVITY; FATAL OUTCOME; HISTAMINE H1 ANTAGONISTS; HUMANS; INFANT; MALE; MANNITOL;

EID: 84885170421     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e31828d5b3e     Document Type: Article

References (16)

1. Lexi-Comp (Lexi-Drugs). In. Ver: 1. 8. 2 ed: Lexi-Comp Inc.
2. Reddy A. Children's Oncology Group ACNS0333, Treatment of Atypical Teratoid/Rhabdoid Tumor (AT/RT) of the Central Nervous System with Surgery, Intensive Chemotherapy, and 3-D Conformal Radiation, a Phase III Group-wide Study. Opened December 8, 2008. Last updated July 4, 2011.
3. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245.
4. Golab W. Mannitol in experimentally induced anaphylactic shock. Pol Med Sci Hist Bull. 1968;11:60-62, passim.
5. Lamb JD, Keogh JA. Anaphylactoid reaction to mannitol. Can Anaesth Soc J. 1979;26:435-436.
6. McNeill IY. Hypersensitivity reaction to mannitol. Drug Intell Clin Pharm. 1985;19:552-553.
7. Biro P, Schmid P, Wuthrich B. A life-threatening anaphylactic reaction following mannitol. Der Anaesthesist. 1992;41: 130-133.
8. Gillespie E, Lichtenstein LM. Histamine release from human leukocytes: studies with deuterium oxide, colchicine, and cytochalasin B. J Clin Invest. 1972;51:2941-2947.
9. Findlay SR, Dvorak AM, Kagey-Sobotka A, et al. Hyperosmolar triggering of histamine release from human basophils. J Clin Invest. 1981;67:1604-1613.
10. Findlay SR, Kagey-Sobotka A, Lichtenstein LM. In vitro basophil histamine release induced by mannitol in a patient with a mannitol-induced anaphylactoid reaction. J Allergy Clin Immunol. 1984;73(5 pt 1):578-583.
11. Rodriguez-Jimenez B, Dominguez-Ortega J, Gonzalez-Garcia JM, et al. Dimenhydrinate-induced fixed drug eruption in a patient who tolerated other antihistamines. J Investig Allergol Clin Immunol. 2009;19:334-335.
12. Saenz de San Pedro B, Quiralte J, Florido JF. Fixed drug eruption caused by dimenhydrinate. Allergy. 2000;55:297.
13. Mitsias DI, Vovolis V. Anaphylaxis to dimenhydrinate caused by the theophylline component. J Investig Allergol Clin Immunol. 2011;21:317-318.
14. Marko NF. Hyperosmolar therapy for intracranial hypertension: time to dispel antiquated myths. Am J Respir Crit Care Med. 2012;185:467-468.
15. Blissitt PA. Controversies in the management of adults with severe traumatic brain injury. AACN Adv Crit Care. 2012; 23:188-203.
16. Nissenson AR, Weston RE, Kleeman CR. Mannitol. West J Med. 1979;131:277-284.